Santhera Pharmaceuticals’ CHF69 Million Royalty And Debt Financing

Homburger advised Santhera Pharmaceuticals Holding AG on the deal.Santhera Pharmaceuticals Holding AG (SIX: SANN) entered into a royalty monetization financing totaling up to USD 38 m…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here